Green Thumb Industries (OTCMKTS:GTBIF) Issues Quarterly Earnings Results

Green Thumb Industries (OTCMKTS:GTBIF) issued its earnings results on Monday. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.03, Zacks reports. The company had revenue of $280.15 million for the quarter, compared to the consensus estimate of $277.01 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.

Green Thumb Industries Price Performance

Shares of GTBIF traded down $0.74 during mid-day trading on Tuesday, hitting $10.07. The stock had a trading volume of 724,883 shares, compared to its average volume of 510,888. The firm has a market cap of $2.14 billion, a P/E ratio of 41.96 and a beta of 1.41. The business has a fifty day moving average price of $11.61 and a 200-day moving average price of $12.57. Green Thumb Industries has a 52 week low of $6.42 and a 52 week high of $16.33.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on GTBIF. Needham & Company LLC lifted their target price on shares of Green Thumb Industries from $15.50 to $17.00 and gave the company a “buy” rating in a research note on Thursday, May 9th. Wedbush raised their price target on Green Thumb Industries from $15.00 to $16.00 and gave the stock an “outperform” rating in a research report on Friday, May 10th.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.